Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Whole-genome CRISPR screening identifies molecular mechanisms of PD-L1 expression in adult T-cell leukemia/lymphoma

Masahiro Chiba, Joji Shimono, Keito Suto, Takashi Ishio, Tomoyuki Endo, Hideki Goto, Hiroo Hasegawa, Michiyuki Maeda, Takanori Teshima, Yibin Yang, Masao Nakagawa

Blood (2024) 143 (14): 1379–1390.

https://doi.org/10.1182/blood.2023021423

Published: 2024

Includes: Supplemental data

Journal Articles

Genome-Wide CRISPR Screen Identifies MAD2L1BP, ANAPC15 and SLC39A7 As Intrinsic Regulators for Brentuximab Vedotin Sensitivity in Peripheral T-Cell Lymphoma Cells

Keito Suto, Masahiro Chiba, Takashi Ishio, Hideki Goto, Tomoyuki Endo, Michiyuki Maeda, Takanori Teshima, Masao Nakagawa

Blood (2023) 142 (Supplement 1): 51.

https://doi.org/10.1182/blood-2023-180348

Published: 2023

Journal Articles

Low-Dose ATG Has the Same Risk of CMV Reactivation after Allogeneic PBSCT As Ptcy, but Letemovir Is Effective in Preventing CMV Reactivation

Takahide Ara, Yuta Hasegawa, Hiroyuki Ohigashi, Toshihiro Matsukawa, Souichi Shiratori, Atsushi Yasumoto, Hideki Goto, Masahiro Onozawa, Masao Nakagawa, Kaoru Kahata, Tomoyuki Endo, Daigo Hashimoto, Takanori Teshima

Blood (2023) 142 (Supplement 1): 3546.

https://doi.org/10.1182/blood-2023-191306

Published: 2023

Journal Articles

Genome-Wide CRISPR Screen Identifies ZNF451 Regulating Sensitivity to Topoisomerase 2 Inhibitors in Peripheral T-Cell Lymphoma Cells

Keito Suto, Masahiro Chiba, Takashi Ishio, Hideki Goto, Tomoyuki Endo, Michiyuki Maeda, Takanori Teshima, Masao Nakagawa

Blood (2023) 142 (Supplement 1): 4182.

https://doi.org/10.1182/blood-2023-180529

Published: 2023

Journal Articles

Calcineurin inhibitor inhibits tolerance induction by suppressing terminal exhaustion of donor T cells after allo-HCT

Blood (2023) 142 (5): 477–492.

https://doi.org/10.1182/blood.2023019875

Published: 2023

Includes: Supplemental data

Journal Articles

Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma

Blood (2022) 139 (10): 1541–1556.

https://doi.org/10.1182/blood.2021012734

Published: 2022

Includes: Supplemental data

Journal Articles

Two -Year Follow-up Data of Phase II Study of Tirabrutinib, a Second-Generation Bruton's Tyrosine Kinase Inhibitor, in Patients with Treatment-Naïve or Relapsed/Refractory Waldenström's Macroglobulinemiatwo -Year Follow-up Data of Phase II Study of Tirabrutinib, a Second-Generation Bruton's Tyrosine Kinase Inhibitor, in Patients with Treatment-Naïve or Relapsed/Refractory Waldenström's Macroglobulinemia

Kenshi Suzuki, Naohiro Sekiguchi, Shinya Rai, Wataru Munakata, Hiroshi Handa, Hirohiko Shibayama, Tomoyuki Endo, Yasuhito Terui, Noriko Iwaki, Noriko Fukuhara, Hiro Tatetsu, Shinsuke Iida, Takayuki Ishikawa, Daisuke Iguchi, Koji Izutsu

Blood (2021) 138 (Supplement 1): 1352.

https://doi.org/10.1182/blood-2021-146744

Published: 2021

Journal Articles

Phase 2 Study of Tirabrutinib (ONO/GS-4059), a Second-Generation Bruton's Tyrosine Kinase Inhibitor, Monotherapy in Patients with Treatment-Naïve or Relapsed/Refractory Waldenström Macroglobulinemia

Wataru Munakata, Naohiro Sekiguchi, MD PhD, Rai Shinya, MD,PhD, Kenshi Suzuki, MD PhD, Hiroshi Handa, MD PhD, Hirohiko Shibayama, MD PhD, Tomoyuki Endo, MD PhD, Yasuhito Terui, MD PhD, Noriko Iwaki, MD PhD, Noriko Fukuhara, MD PhD, Hiro Tatetsu, MD PhD, Shinsuke Iida, MD PhD, Takayuki Ishikawa, MD PhD, Ryota Shiibashi, Koji Izutsu, MD PhD

Blood (2019) 134 (Supplement_1): 345.

https://doi.org/10.1182/blood-2019-124614

Published: 2019

Journal Articles

Prospective Evaluation of Alternative Donor from Unrelated Volunteer Donor and Cord Blood in Adult Acute Leukemia and Myelodysplastic Syndrome: No Difference between Unrelated Donor and Cord Blood

Blood (2019) 134 (Supplement_1): 4587.

https://doi.org/10.1182/blood-2019-124634

Published: 2019

Journal Articles

Prognostic Significance of Cytogenetic Abnormalities for Patients with Acute Lymphoblastic Leukemia, a Region-Wide Retrospective Study

Blood (2019) 134 (Supplement_1): 5202.

https://doi.org/10.1182/blood-2019-125084

Published: 2019

Journal Articles

Feasibility and Kinetics of CD34+ Hematopoietic Cells Mobilization By Low-Dose Pegfilgrastim in Lymphoma Patients

Hideki Goto, MDPhD, Daisuke Hidaka, MD, Satoshi Yamamoto, MD PhD, Koji Hayasaka, Rie Michimata, Ikuko Kagawa, Kana Sunagoya, Hiroaki Iijima, Eiko Hayase, MD, Souichi Shiratori, MD PhD, Kohei Okada, MD PhD, Junichi Sugita, MD PhD, Masahiro Onozawa, MD PhD, Daigo Hashimoto, MD PhD, Kaoru Kahata, MD PhD, Katsuya Fujimoto, MD PhD, Tomoyuki Endo, MD PhD, Chikara Shimizu, MD PhD, Takanori Teshima, MD PhD

Blood (2017) 130 (Supplement 1): 4478.

https://doi.org/10.1182/blood.V130.Suppl_1.4478.4478

Published: 2017

Journal Articles

Intrabone Transplantation of a Single Cord Blood Unit Using Non-Irradiated Reduced-Intensity Conditioning

Blood (2016) 128 (22): 3390.

https://doi.org/10.1182/blood.V128.22.3390.3390

Published: 2016

Journal Articles

Lymphopenia and an Elevated Monocyte Count At Diagnosis Do Not Predict a Poor Outcome After Autologous Transplants for Diffuse Large B-Cell Lymphoma in the First Remission

Mitsufumi Nishio, MD, PhD, Satoshi Yamamoto, MD, PhD, Tomoyuki Endo, MD, PhD, Katsuya Fujimoto, MD, PhD, Toshiya Sakai, MD, PhD, Takeshi Kondo, MD, PhD, Akio Shigematsu, MD, PhD, Junichi Sugita, MD, PhD, Satoshi Hashino, MD, PhD, Junji Tanaka, M.D., Masahiro Imamura, MD, PhD, Takanori Teshima, MD, PhD

Blood (2012) 120 (21): 4544.

https://doi.org/10.1182/blood.V120.21.4544.4544

Published: 2012

Journal Articles

Molecular and Pathological Analysis of DOCK Family Proteins in Hematopoietic Malignancy

Hiroshi Nishihara, MD., PhD., Lei Wang, PhD., Mitsufumi Nishio, MD, PhD, Tomoyuki Endo, MD, PhD, Katsuya Fujimoto, MD, PhD, Masato Obara, MD, PhD, Shinya Tanaka, MD., PhD.

Blood (2011) 118 (21): 5230.

https://doi.org/10.1182/blood.V118.21.5230.5230

Published: 2011

Journal Articles

Comparison of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Extranodal NK/T-Cell Lymphoma, Nasal Type: Analysis of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) Lymphoma Working Group

Ritsuro Suzuki, MD, PhD, Shinichi Kako, MD, Rie Hyo, MD, Koji Izutsu, MD, PhD, Toshiro Ito, MD, Katsuji Shinagawa, Tomoyuki Endo, MD, PhD, Hisashi Sakamaki, MD, Junji Suzumiya, MD, PhD

Blood (2011) 118 (21): 503.

https://doi.org/10.1182/blood.V118.21.503.503

Published: 2011

Journal Articles

Both DOCK180 and DOCK2 Participate in the CXCL12 and CCL19 Dependent Chemotaxis of Human Dendritic Cells Derived From Monocytes Through the Activation of Rac

Hideki Goto, MD, PhD, Mitsufumi Nishio, MD, PhD, Katsuya Fujimoto, MD, PhD, Tomoyuki Endo, MD, PhD, Masato Obara, MD, PhD, Keisuke Yamaguchi, MD, PhD, Yukari Takeda, MD, PhD, Hiroshi Nishihara, MD, PhD, Takao Koike, MD, PhD, Masahiro Imamura, MD, PhD

Blood (2011) 118 (21): 521.

https://doi.org/10.1182/blood.V118.21.521.521

Published: 2011

Journal Articles

FCGR3A-158V/F Polymorphism May Correlate with the Levels of Immunoglobulin in Patients with Non-Hodgkin’s Lymphoma after Rituximab Treatment as An Adjuvant to Autologous Stem Cell Transplantation.

Mitsufumi Nishio, MD, PhD, Tomoyuki Endo, M.D., Ph.D., Katsuya Fujimoto, M.D., Ph.D., Satoshi Yamamoto, M.D., Ph.D., Masato Obara, M.D., Keisuke Yamaguchi, M.D., Yukari Takeda, M.D., Hideki Goto, M.D., Ikumi Kasahara, M.D., Norihiro Sato, M.D., Ph.D., Takao Koike, M.D., Ph.D.

Blood (2008) 112 (11): 3245.

https://doi.org/10.1182/blood.V112.11.3245.3245

Published: 2008

Journal Articles

DOCK180, a New Surrogate Marker to Distinguish CD34 Positive Acute Leukemia Cells from CD34 Positive Normal Hematopoietic Stem/Progenitor Cells.

Mitsufumi Nishio, MD, PhD, Kohki Kumano, M.D., Ph.D., Katsuya Fujimoto, M.D., Ph.D., Tomoyuki Endo, M.D., Ph.D., Satoshi Yamamoto, M.D., Ph.D., Akio Shigematsu, MD, PhD, Takeshi Kondo, MD., PhD, Junji Tanaka, MD, PhD, Satoshi Hashino, Masahiro Imamura, Hiroshi Nishihara, M.D., Ph.D., Norihiro Sato, M.D., Ph.D., Takao Koike, M.D., Ph.D.

Blood (2008) 112 (11): 1476.

https://doi.org/10.1182/blood.V112.11.1476.1476

Published: 2008

Journal Articles

Chronic Lymphocytic Leukemia Cells Produce a Soluble Factor(s) That Can Induce CD14+ Blood Mononuclear Cells To Assume Properties of Nurselike Cells In Vitro.

Davorka Messmer, PhD, Hsu-Hsiang Chang, Tomoyuki Endo, M.D., Thomas J. Kipps, M.D., Ph.D.

Blood (2007) 110 (11): 1136.

https://doi.org/10.1182/blood.V110.11.1136.1136

Published: 2007

Journal Articles

Chronic Lymphocytic Leukemia Cells Can Induce Monocytes to Express High Levels of BAFF and Assume Properties of Nurselike Cells In Vitro.

Davorka Messmer, PhD, Tomoyuki Endo, M.D., Bradley T. Messmer, Ph.D., Thomas J. Kipps, M.D. Ph.D.

Blood (2006) 108 (11): 588.

https://doi.org/10.1182/blood.V108.11.588.588

Published: 2006

NARROW

Whole-genome CRISPR screening identifies molecular mechanisms of PD-L1 expression in adult T-cell leukemia/lymphoma

Genome-Wide CRISPR Screen Identifies MAD2L1BP, ANAPC15 and SLC39A7 As Intrinsic Regulators for Brentuximab Vedotin Sensitivity in Peripheral T-Cell Lymphoma Cells

Low-Dose ATG Has the Same Risk of CMV Reactivation after Allogeneic PBSCT As Ptcy, but Letemovir Is Effective in Preventing CMV Reactivation

Genome-Wide CRISPR Screen Identifies ZNF451 Regulating Sensitivity to Topoisomerase 2 Inhibitors in Peripheral T-Cell Lymphoma Cells

Calcineurin inhibitor inhibits tolerance induction by suppressing terminal exhaustion of donor T cells after allo-HCT

Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma

Phase 2 Study of Tirabrutinib (ONO/GS-4059), a Second-Generation Bruton's Tyrosine Kinase Inhibitor, Monotherapy in Patients with Treatment-Naïve or Relapsed/Refractory Waldenström Macroglobulinemia

Prospective Evaluation of Alternative Donor from Unrelated Volunteer Donor and Cord Blood in Adult Acute Leukemia and Myelodysplastic Syndrome: No Difference between Unrelated Donor and Cord Blood

Prognostic Significance of Cytogenetic Abnormalities for Patients with Acute Lymphoblastic Leukemia, a Region-Wide Retrospective Study

Feasibility and Kinetics of CD34+ Hematopoietic Cells Mobilization By Low-Dose Pegfilgrastim in Lymphoma Patients

Intrabone Transplantation of a Single Cord Blood Unit Using Non-Irradiated Reduced-Intensity Conditioning

Lymphopenia and an Elevated Monocyte Count At Diagnosis Do Not Predict a Poor Outcome After Autologous Transplants for Diffuse Large B-Cell Lymphoma in the First Remission

Molecular and Pathological Analysis of DOCK Family Proteins in Hematopoietic Malignancy

Comparison of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Extranodal NK/T-Cell Lymphoma, Nasal Type: Analysis of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) Lymphoma Working Group

Both DOCK180 and DOCK2 Participate in the CXCL12 and CCL19 Dependent Chemotaxis of Human Dendritic Cells Derived From Monocytes Through the Activation of Rac

FCGR3A-158V/F Polymorphism May Correlate with the Levels of Immunoglobulin in Patients with Non-Hodgkin’s Lymphoma after Rituximab Treatment as An Adjuvant to Autologous Stem Cell Transplantation.

DOCK180, a New Surrogate Marker to Distinguish CD34 Positive Acute Leukemia Cells from CD34 Positive Normal Hematopoietic Stem/Progenitor Cells.

Chronic Lymphocytic Leukemia Cells Produce a Soluble Factor(s) That Can Induce CD14+ Blood Mononuclear Cells To Assume Properties of Nurselike Cells In Vitro.

Chronic Lymphocytic Leukemia Cells Can Induce Monocytes to Express High Levels of BAFF and Assume Properties of Nurselike Cells In Vitro.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only